These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15236286)
1. Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7. Tancabelic J; Haun SE Pediatr Blood Cancer; 2004 Aug; 43(2):170-6. PubMed ID: 15236286 [TBL] [Abstract][Full Text] [Related]
2. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Brady KM; Easley RB; Tobias JD Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833 [TBL] [Abstract][Full Text] [Related]
4. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation. Fischer D; Schloesser R; Buxmann H; Veldman A J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565 [TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M; Crit Care; 2006; 10(6):R178. PubMed ID: 17184516 [TBL] [Abstract][Full Text] [Related]
6. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260 [TBL] [Abstract][Full Text] [Related]
7. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Levi M; Toh CH; Thachil J; Watson HG Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477 [TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322 [TBL] [Abstract][Full Text] [Related]
9. Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. Das P; Carcao M; Hitzler J Pediatr Blood Cancer; 2006 Aug; 47(2):206-9. PubMed ID: 16007583 [TBL] [Abstract][Full Text] [Related]
10. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. Pepas LP; Arif-Adib M; Kadir RA Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493 [TBL] [Abstract][Full Text] [Related]
12. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Cheng LL; Ng PC; Chan PK; Wong HL; Cheng FW; Tang JW Pediatrics; 2006 Sep; 118(3):e929-33. PubMed ID: 16908622 [TBL] [Abstract][Full Text] [Related]
13. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding. Hirasaki Y; Suematsu Y; Yasuda T; Tajima K Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190 [No Abstract] [Full Text] [Related]
14. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160 [TBL] [Abstract][Full Text] [Related]
15. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery. Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563 [TBL] [Abstract][Full Text] [Related]
16. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report. Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086 [TBL] [Abstract][Full Text] [Related]
18. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath. Karimi M Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432 [TBL] [Abstract][Full Text] [Related]
19. The use of activated recombinant factor VII in a patient with fulminant hepatic failure requiring placement of an intracranial pressure monitor. Meadows HB; Krisl JC; Greenberg CS; Mazur JE Ann Pharmacother; 2011 Nov; 45(11):e60. PubMed ID: 22028416 [TBL] [Abstract][Full Text] [Related]
20. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Pavese P; Bonadona A; Beaubien J; Labrecque P; Pernod G; Letoublon C; Barnoud D Can J Anaesth; 2005 Jan; 52(1):26-9. PubMed ID: 15625252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]